JT Gains World-First Topical JAK Inhibitor Approval

Japan Nod In Competitive Dermatitis Space

 
• By Ian Haydock

Latest new drug approvals in Japan include the first anywhere for a topical JAK inhibitor and also a marketing clearance for a new contender in the large prostate cancer space.

Japan_Approval
Pioneering Approval In Japan • Source: Shutterstock

More from Japan

More from Focus On Asia